Forian Inc
NASDAQ:FORA

Watchlist Manager
Forian Inc Logo
Forian Inc
NASDAQ:FORA
Watchlist
Price: 2.01 USD -5.19% Market Closed
Market Cap: 62.4m USD
Have any thoughts about
Forian Inc?
Write Note

Forian Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Forian Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Forian Inc
NASDAQ:FORA
Revenue
$19.7m
CAGR 3-Years
90%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Revenue
$2.7B
CAGR 3-Years
15%
CAGR 5-Years
21%
CAGR 10-Years
25%
Inspire Medical Systems Inc
NYSE:INSP
Revenue
$755.6m
CAGR 3-Years
55%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Revenue
$475.4m
CAGR 3-Years
32%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Revenue
$1.1B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
10%
W
Waystar Holding Corp
NASDAQ:WAY
Revenue
$791m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Forian Inc
Glance View

Market Cap
62.5m USD
Industry
Health Care

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.

FORA Intrinsic Value
2.04 USD
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Forian Inc's Revenue?
Revenue
19.7m USD

Based on the financial report for Sep 30, 2024, Forian Inc's Revenue amounts to 19.7m USD.

What is Forian Inc's Revenue growth rate?
Revenue CAGR 5Y
12%

Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for Forian Inc have been 90% over the past three years , 12% over the past five years .

Back to Top